SK Biopharmaceuticals Co Ltd
KRX:326030
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
KR |
|
Cognor Holding SA
F:WO9
|
PL |
|
Ecoslops SA
PAR:ALESA
|
FR |
|
E
|
Earth Life Sciences Inc
OTC:CLTS
|
CA |
|
D
|
DO & CO AG
XMUN:DOQ
|
AT |
|
A
|
Alstom SA
XHAN:AOMD
|
FR |
|
Crosswood SA
PAR:CROS
|
FR |
|
M
|
Maxim Power Corp
OTC:MXGFF
|
CA |
|
Verimatrix SA
PAR:VMX
|
FR |
|
Genoway SA
F:JEH
|
FR |
|
Quebecor Inc
F:QB3
|
CA |
|
A
|
Amplefield Ltd
SGX:AOF
|
MY |
|
Fathom Holdings Inc
NASDAQ:FTHM
|
US |
|
S
|
SI-BONE Inc
F:2K3
|
US |
|
L
|
Leo Global Logistics PCL
SET:LEO
|
TH |
|
Temple & Webster Group Ltd
F:2Q9
|
AU |
|
G
|
Grenergy Renovables SA
F:5GR
|
ES |
Shareholder Yield
Current shareholder yield for SK Biopharmaceuticals Co Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
SK Biopharmaceuticals Co Ltd
| Average Annual Return | -0.04% |
| Standard Deviation of Annual Returns | 30.81% |
| Max Drawdown | -53% |
| Market Capitalization | 6.2T KRW |
| Shares Outstanding | 78 310 000 |
| Percentage of Shares Shorted |
N/A
|
